News
American BioMed Signs Distribution Agreements With
Hinck Medical and CVC, Inc.
THE WOODLANDS, Texas--(BW HealthWire)--Dec. 2, 1997--American BioMed, Inc. (OTC
Bulletin Board: ABMI - news), a manufacturer of minimally invasive medical devices for the
treatment of cardiovascular disease, today announced it has signed two additional U.S. distribution
agreements with Hinck Medical and CVC, Inc. for its 100% silicone- based balloon catheter
product line.
Hinck Medical of Beaverton, Oregon, a well-established specialty medical products distributor
serving the Northwestern U.S. market, will focus its sales efforts in Oregon, Washington, Montana
and Idaho. In preparation for the full-scale promotion of the company's products, Hinck's sales
staff has received intensive training on the use of American BioMed's silicone-based balloon
catheter technology.
CVC, Inc. of Arlington, Texas (http://www.cvcinc.com), one of the fastest growing specialty
medical product distributors in the U.S., will concentrate its sales efforts in the Southwest and
Rocky Mountain regions. Both Hinck and CVC have placed initial stocking orders with American
BioMed to support their preliminary promotional and distribution efforts. These orders have been
filled, and initial payment will be recorded in the fourth quarter of 1997.
Commenting on the announcement, Steven B. Rash, president and chief executive officer, stated,
''The addition of Hinck and CVC to our expanding distribution network fits well with our overall
growth strategy to gain immediate access to important regions throughout the United States for the
company's products. These two companies place a strong emphasis on quality salesmanship,
education/training and customer service support, which we believe will strengthen American
BioMed's visibility in the marketplace. These additional agreements validate the company's
ongoing commitment to continue developing strategic partnerships with key distributors to broaden
the market for our unique line of products.''
The company has nine FDA-cleared balloon catheters, six of which are currently marketed
worldwide. The 100%-silicone design of these catheters is resistant to environmental factors,
unaffected by body temperature and more bio-compatible than latex balloons or polyvinyl chloride
tubing. The patented one-piece balloon design eliminates glue and ties, providing superior
smoothness and preventing the possibility of balloon dislodgement. Allergy to latex has been
increasingly recognized as a cause of life- threatening intraoperative anaphylaxis (a systemic
reaction). Frequent use of latex in patients or by healthcare workers can result in sensitization that
may place some individuals at risk for life-threatening allergic reactions. The 100%-silicone design
of the company's catheters negates the potential risk of intraoperative anaphylaxis.
Good Luck To All |
